DBVT - DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript
2024-07-30 22:03:01 ET
DBV Technologies S.A. (DBVT)
Q2 2024 Earnings Conference Call
July 30, 2024 5:30 PM ET
Company Participants
Katie Matthews – Investor Relations
Daniel Tassé – Chief Executive Officer
Pharis Mohideen – Chief Medical Officer
Virginie Boucinha – Chief Financial Officer
Conference Call Participants
Jon Wolleben – Citizens JMP
Presentation
Operator
Welcome to the DBV Second Quarter Financial Results and Business Update Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Katie Matthews, Investor Relations. Please go ahead.
Katie Matthews
Thank you. This afternoon, DBV Technologies issued a press release that outlines our financial results for the three and six months ended June 30, 2024. This press release is available in the Press Releases section of the DBV Technologies website. Before we begin, please note that today’s call may include a number of forward-looking statements including, but not limited to comments regarding our clinical and regulatory development plans, the design of our anticipated clinical trials, the timing and results of interactions with regulatory agencies, our forecast of our cash runway and the ability of any of our product candidates, if approved, to improve the lives of patients with food allergies....
DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript